MassDevice.com +3 | The top 3 medtech stories for December 15, 2015

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. Study: Boston Scientific’s Watchman cheaper than drugs in reducing afib stroke risk A study comparing the stroke risk for atrial fibrillation patients treated with Boston Scientific‘s Watchman device with the anticoagulant drug warfarin and non-warfarin oral anticoagulants found Watchman to be more cost-effective than its counterparts. Watchman is a catheter-delivered cardiac implant designed to close off the left atrial appendage, to prevent blood clots from forming there that could later cause a stroke. Read more 2. Stryker loses bid to toss ex-sales rep’s counter-claims Stryker this month lost a bid for summary judgment in a lawsuit against a former sales rep who jumped ship for Zimmer Biomet. Stryker in 2013 sued a pair of former sales agents, Christopher Ridgeway and Richard Steitzer, accusing them of scheming to poach reps and business from Stryker in Louisiana and New York. Stryker fired Ridgeway in September 2013, after discovering that he was allegedly running a pair of medical supply businesses on the side. In June of that year, Stryker alleged, Biomet began courting Ridgeway, allegedly looking to bring his entire Stryker ...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 3 Source Type: news